300705 logo

Hunan Jiudian Pharmaceutical Co., Ltd. Stock Price

SZSE:300705 Community·CN¥6.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

300705 Share Price Performance

CN¥12.62
-6.22 (-33.01%)
CN¥12.62
-6.22 (-33.01%)
Price CN¥12.62

300705 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and fair value.

1 Risk
3 Rewards

Hunan Jiudian Pharmaceutical Co., Ltd. Key Details

CN¥3.0b

Revenue

CN¥862.5m

Cost of Revenue

CN¥2.1b

Gross Profit

CN¥1.7b

Other Expenses

CN¥403.8m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 22, 2026
0.82
71.35%
13.41%
24.4%
View Full Analysis

About 300705

Founded
2001
Employees
2298
CEO
Yang Yang
WebsiteView website
www.hnjiudian.com

Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers chemical drug preparations, active pharmaceutical ingredients (APIs), pharmaceutical excipients, traditional Chinese medicine, health foods, and rehabilitation and wellness products. Its products portfolio includes loxoprofen sodium gel patches, ketoprofen gel patches, pantopril sodium enteric-coated tablets, dapagliflozin tablets, and rosuvastatin calcium. It also provides digestive system and metabolic, nervous system, cardiovascular system medications, musculoskeletal, anti-infective, respiratory system medications, blood and hematopoietic system, and reproductive and urinary system and hormone drugs. In addition, the company offers CMO/CDMO; software development and technical; and pharmaceutical retail services. Hunan Jiudian Pharmaceutical Co., Ltd. was founded in 2001 and is based in Changsha, China.

Recent 300705 News & Updates

Recent updates

No updates